NewsSource: EClinCloud

Product Overview | eCOA · Electronic Clinical Outcome Assessment System

2 min readEClinCloud Editorial Team
Article image

Source: EClinCloud. Author: EClinCloud.

Article image


On September 3, 2021, the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) released the "Guidance on the Application of Patient-Reported Outcomes in Drug Clinical Research (Draft for Comment)" for public consultation, and in this draft guidance clarified the standards for using electronic patient-reported outcomes (ePRO). Both policy encouragement and technological development have driven the digital transformation of clinical outcome assessment (COA).


What is EClinCloud eCOA?

EClinCloud eCOA is an electronic clinical trial tool that can easily, thoroughly, accurately, and in real time collect standardized scale data from clinicians (ClinRO), patients (PRO), non-clinician observers (ObsRO), or performance-based assessments (PerfO), as well as custom diary data such as adverse reactions (SAE) and dosing diaries.


01

Streamline management processes and reduce missing data

Eliminate administrative errors and data loss that may occur when study sites manage paper-based COAs.


Article image


Article image


02

Flexible notification configuration to improve subject compliance

By configuring notifications, multi-party and repeated reminders can be sent to ensure subjects complete their entries on time.


Article image



03

Built-in customized training to assist subjects in completing entries efficiently

Training programs can be customized for each study so subjects know how to complete entries and are willing to do so, improving completion efficiency.


Article image



04

Intelligent assistance system to improve data accuracy

Eliminate ambiguous and conflicting data through built-in logic and error-checking functions.


Article image



What are the features of the EClinCloud eCOA system?

Article image



What services can EClinCloud eCOA provide?

Under the guidance of experienced eCOA specialists, EClinCloud's dedicated eCOA team provides sponsors with a one-stop solution.


● A professional medical team that designs optimal electronic completion workflows based on scientific considerations.


● A strong scale team providing end-to-end services including scale copyright, translation, and linguistic validation.


● A rigorous data management team providing professional data services including database build, standard reports, and custom report development.


● An efficient project management team providing end-to-end project management, customized device management, and related services.


● A 24/7 online customer support team providing timely user assistance.


● Bringing together physician expert resources to provide clients with more professional and reliable services.



Why choose EClinCloud's eCOA?

Article image


| About EClinCloud |

EClinCloud is a healthcare and life sciences technology company rooted in China and serving the world. Guided by its mission of "bringing effective treatments to patients through technological innovation," and driven by science and medicine, it combines digital technology with life sciences data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



Article image

Read the original WeChat post

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.